Beta adrenergic blokade in myocardial infarction

Beta adrenergic blokade in myocardial infarction

<p>This thesis is concerned with the influence of acute and long-term beta-adrenergic blockade on myocardial infarction in man. An original statistical evaluation of all published and some available unpublished clinical trials is presented in Chapter I.</p> <p>Chapter III and TV c...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Yusuf, S
Altri autori:	Sleight, P
Natura:	Tesi
Lingua:	English
Pubblicazione:	1980
Soggetti:	Myocardial infarction Adrenergic beta blockers

Documenti analoghi

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
di: Roberto F.E. Pedretti
Pubblicazione: (2018-06-01)

Beta adrenergic blockers poisoning
di: Tadić Milorad, et al.
Pubblicazione: (2016-01-01)

Beta-adrenergic reactivity of erythrocytes and the progression of heart failure in patients after myocardial infarction
di: A. A. Garganeeva, et al.
Pubblicazione: (2020-02-01)

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
di: A. N. Zakirova, et al.
Pubblicazione: (2017-12-01)

Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
di: Seung-Jae Joo
Pubblicazione: (2023-08-01)

Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failure
di: Claire Baudier, et al.
Pubblicazione: (2023-10-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
di: B. N. Garifullin, et al.
Pubblicazione: (2016-01-01)

Comparative analysis of adrenergic reactivity of erythrocytes in patients with myocardial infarction depending on the severity of coronary obstruction
di: D. A. Vorobyova, et al.
Pubblicazione: (2020-06-01)

The bisoprolol efficiency predictors in patients with stable angina after myocardial infarction
di: O. V. Zamakhina, et al.
Pubblicazione: (2019-04-01)

BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE
di: Liana E. Kafetzopoulou, et al.
Pubblicazione: (2013-03-01)

Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study
di: Sheng-Fu Liu, et al.
Pubblicazione: (2021-09-01)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
di: Liyew Desta, et al.
Pubblicazione: (2021-02-01)

Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease
di: Andrew K. Evans, et al.
Pubblicazione: (2020-12-01)

Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction
di: Wei-Ping Huang, et al.
Pubblicazione: (2018-01-01)

Treatment and secondary prevention of myocardial infarction
di: E. V. Kuleshova, et al.
Pubblicazione: (2013-12-01)

Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
di: V. N. Larina, et al.
Pubblicazione: (2021-11-01)

Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction
di: Fatih Kahraman, et al.
Pubblicazione: (2022-04-01)

Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension
di: Maryam Izadi, et al.
Pubblicazione: (2024-10-01)

Regulation of bone formation and resorption by Beta Adrenergic system
di: Fateme Mohammadali, et al.
Pubblicazione: (2016-04-01)

The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
di: Oriol Iborra-Egea, et al.
Pubblicazione: (2022-07-01)

β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
di: Tora Hagsund, et al.
Pubblicazione: (2020-04-01)

The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues
di: Lauriane Y. M. Michel, et al.
Pubblicazione: (2020-12-01)

EFFICACY AND SAFETY OF BETA-ADRENOBLOCKER TREATMENT DURING POSTOPERATIONAL PERIOD AFTER EXTRACARDIAL SURGERY - A PARADIGM SHIFT?
di: Yu. V. Shchukin, et al.
Pubblicazione: (2014-09-01)

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
di: Ali H. Zahalka, et al.
Pubblicazione: (2024-11-01)

Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
di: Mengjin Hu, et al.
Pubblicazione: (2022-08-01)

Comparative Effectiveness of Long‐Term Maintenance Beta‐Blocker Therapy After Acute Myocardial Infarction in Stable, Optimally Treated Patients Undergoing Percutaneous Coronary Intervention
di: Myunhee Lee, et al.
Pubblicazione: (2023-08-01)

THE USE OF INTRAVENOUS FORMS OF BETA-BLOCKERS IN ACUTE CORONARY SYNDROME
di: I. D. Astrakhantseva, et al.
Pubblicazione: (2017-06-01)

Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence
di: Mochamad Yusuf Alsagaff, et al.
Pubblicazione: (2021-11-01)

Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study
di: Christel Bruggmann, et al.
Pubblicazione: (2020-08-01)

Beta Blocker Overdose: A Case for High-Fidelity Simulation in Emergency Medicine
di: Michael Fitch, et al.
Pubblicazione: (2010-01-01)

Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report
di: Alvise Tosoni, et al.
Pubblicazione: (2017-11-01)

Intravenous ephedrine abolished suspected bronchoconstriction during general anesthesia in a patient undergoing beta-adrenergic blocker therapy for hypertension
di: Hiroyuki Oshika, et al.
Pubblicazione: (2019-01-01)

Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry
di: Jaehoon Chung, et al.
Pubblicazione: (2021-03-01)

Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
di: Xue-song Wen, et al.
Pubblicazione: (2022-04-01)

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
di: Jaehoon Chung, et al.
Pubblicazione: (2017-10-01)

Targeting cardiac beta-adrenergic signaling via GRK2 inhibition for heart failure therapy
di: Alessandro eCannavo, et al.
Pubblicazione: (2013-09-01)

ADRB2 polymorphisms predict the risk of myocardial infarction and coronary artery disease
di: Dong-Wei Wang, et al.
Pubblicazione: (2015-01-01)

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic
di: Elena Olmastroni, et al.
Pubblicazione: (2022-12-01)

Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?—Lessons Learned From Cancer
di: Antonio Barbieri, et al.
Pubblicazione: (2020-09-01)

Beta-adrenergic blocking agents in cutaneous and oral melanoma
di: Sivakamavalli Jeyachandran
Pubblicazione: (2024-06-01)